Healthcare costs are expected to rise by nearly 8% in 2025 ... In addition, more people are using GLP-1 weight loss drugs, including Ozempic, Wegovy, Zepbound and Mounjaro, to treat diabetes, obesity ...

However, their high monthly costs — ranging from $1,000 to $1,500 — are placing considerable financial pressure on employer-sponsored healthcare plans. According to a 2024 survey by the Business Group ...

GLP-1 medications such as Wegovy, Mounjaro and Ozempic helped drive a 9% year-over-year increase in U.S. prescription dispensing revenue, which reached $683 billion in 2024.. A separate report ...

CBIZ Report Highlights Rising Costs: Surge in Inpatient and Outpatient Expenses, Popular GLP-1 Drugs like Ozempic Drive Pharmacy Spend Increase New CBIZ State of Healthcare Report Reveals Cost ...

Some consumers are taking smaller than standard doses of GLP-1s—the popular class of weight-loss and diabetes drugs that include Ozempic, Wegovy, and Zepbound—or spacing out doses longer than ...

To help, 19 Forbes Business Council members share additional steps healthcare companies can take to grapple with rising costs while maintaining quality care for patients. 1. Shift To A Proactive ...

The unions that represent some 75,000 public sector workers in N.J. demand action, call for legislation to ensure affordable healthcare and improved governance and transparency of New Jersey's ...